This webinar focuses on the baseline assessment of shortness of breath and the association with early or established interstitial lung disease.
Learning Objectives
Dr Vasilis Kouranos Background
Dr Vasilis Kouranos is highly specialised in pulmonary fibrosis and interstitial lung diseases such as idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung diseases at Royal Brompton Hospital.
He has sub-specialist expertise in sarcoidosis and particularly cardiac sarcoidosis, which was the subject of his PhD thesis. He also offers clinical support for sarcoidosis and ILD patients with lung cancer.
This talk delves into antifungal prophylaxis in lung transplant patients, discussing the myths and the reality with the support of studies.
Professor Salman reflects on his experience and outputs from an MRC/EPSRC molecular pathology node in breath biomarkers, providing insights of outcomes.
Dr Wechalekar provides an overview of the importance of nuclear cardiology, focusing on common and uncommon applications in cardiac imaging.
This talk discusses how airway microbial communities may interact with the airway mucosa to maintain health to resist infection.
This talk discusses the epidemiology, presentation, diagnosis and management of interstitial lung diseases, focusing on pulmonary fibrosis.
This talk provides insights of early diagnostic work up and pitfalls, modern treatment concepts and the pre-emptive measure and aftercare of aortic dissection.
This talk provides an overview of ‘phenotypes’ in patients with persistent post-COVID lung disease, reviewing Dr Ravaglia’s findings based on biopsies of post-COVID changes.
Dr Samantha Sonnappa discusses the causes of recurrent chest infections in infants and children and the challenges that primary care face to determine the problem.
Dr Lee provides an update on the journey towards national roll out of the NHS England lung cancer screening programme, showcasing his research of early diagnosis of lung cancer.
This talk provides insights into the association of COPD and bronchiectasis, reviewing a collaboration study investigating the risk of hospitalisation for community acquired pneumonia in patients.
This talk discusses the importance of understanding the developments and implications of early COPD, to prevent progression to a more substantial disease.
This talk focuses on pharmacological management of Heart Failure (HF), the new ESC HF guidelines and the implications of modern HF therapy.